Flotek Industries, Inc. — 2012 Form 10-K
Reporting period: Fiscal year ended December 31, 2012. The filing also presents unaudited fourth-quarter results. Flotek supplies specialty oilfield chemicals and logistics, drilling products, and artificial-lift equipment and services.
Financial performance and liquidity
| Metric | 2012 | 2011 | Change |
|---|---|---|---|
| Revenue | $312.8 million | $258.8 million | +20.9% |
| Gross margin | $131.6 million; 42.1% | $105.8 million; 40.9% | Margin +1.2 percentage points |
| Operating income | $58.6 million; 18.7% of revenue | $48.9 million; 18.9% of revenue | +18.7% |
| Net income | $49.8 million | $31.4 million | +58.5% |
| Net income attributable to common stockholders | $49.8 million | $26.5 million | Up from $0.60 to $1.03 basic EPS |
| Operating cash flow | $49.5 million | $32.4 million | +52.7% |
| Capital expenditures | $20.7 million | $10.0 million | More than doubled |
Fourth-quarter 2012 revenue was $76.7 million versus $74.9 million in fourth-quarter 2011; net income was $23.2 million versus $1.0 million. Quarterly figures are unaudited.
Cash and cash equivalents fell to $2.7 million from $46.7 million, largely reflecting debt repayments. Current assets were $96.2 million and current liabilities $41.9 million at year-end. Cash flow from operations less capital expenditures was approximately $28.8 million.
Year-end debt included a $25.0 million term loan, $5.2 million of convertible notes, and $1.8 million of capital lease obligations. The $50 million revolving facility was undrawn, with approximately $47.2 million available under its borrowing base. In February 2013, Flotek repaid the remaining $5.2 million of convertible notes; it reported no convertible notes outstanding afterward. The term loan bears a variable rate (4.75% at year-end), is secured by substantially all domestic equipment and other intangible assets, and matures in December 2017.
Material changes and segment results
- Chemicals and Logistics: Revenue rose 30.6% to $184.0 million; operating income increased 50.3% to $65.4 million. Growth was led by CnF products and stimulation liquids, with improved product mix, sourcing savings, and operating efficiencies supporting margins.
- Drilling Products: Revenue rose 13.9% to $116.7 million, but operating income declined 3.3% to $22.3 million. Higher employee-related and motor repair costs weighed on results.
- Artificial Lift: Revenue fell 21.8% to $12.1 million and operating income fell 21.0% to $3.4 million, as weak natural-gas prices and lower gas-directed activity reduced installs, workovers, and valve sales.
- Top three customers represented 35% of consolidated revenue, up from 28% in 2011; two customers each accounted for about 16% and 10% in 2012. More than 95% of revenue from the major customers cited was in Chemicals.
Outlook, risks, and unusual items
Management described the industry outlook as cautiously favorable, assuming broadly sustained activity. It expected oil-directed and horizontal drilling to support demand, while warning that cost pressures could stall margin improvement. The filing gives no specific 2013 revenue or earnings guidance. Planned 2013 capital expenditures were approximately $19.3 million; management expected R&D spending to remain near 2012’s $3.2 million.
- 2012 earnings included a $4.3 million income-tax benefit, primarily reflecting a $16.5 million reduction in a valuation allowance on deferred tax assets. The benefit is not equivalent to recurring operating performance.
- Flotek recorded $7.3 million in losses on debt extinguishment and a $2.6 million noncash gain from changes in warrant fair value. Warrant amendments in June 2012 allowed the warrants to be reclassified from liabilities to equity, ending subsequent fair-value remeasurement under the disclosed terms.
- Management and the independent auditor concluded that internal control over financial reporting was ineffective at December 31, 2012. Material weaknesses involved ERP access segregation and reporting, as well as account reconciliations and monthly-close variance analysis. Remediation was underway, with no assurance it would succeed.
- Key risks include oil and gas activity and commodity-price volatility, customer concentration, limited-source chemical inputs and reliance on certain suppliers, competition and pricing pressure, environmental and hydraulic-fracturing regulation, foreign-market risks, and variable-rate borrowing.
- The company reported routine litigation but no pending or threatened proceedings expected to materially affect financial position, results, or liquidity. It reported no material off-balance-sheet arrangements.
Important facts for investors to verify
- Whether internal-control remediation addressed the disclosed material weaknesses, particularly following the ERP implementation.
- How much 2012 net income depended on the deferred-tax valuation-allowance release and other nonrecurring or noncash items.
- Whether operating cash generation can sustain planned capital spending while rebuilding cash and servicing the term loan.
- Whether customer concentration and Chemicals’ growth in CnF sales are sustainable, and whether weaker Artificial Lift demand persists.
- Current borrowing-base availability, variable-rate exposure, debt covenant compliance, and the status of the convertible-note repayment reported as a subsequent event.